New Pentagon guidelines temporarily rescind testosterone screening for US Army troops: Report
Pentagon temporarily rescinds new mandatory testosterone deficiency screening guidance for troops aged 30+, saying updates are needed.
The Pentagon has temporarily withdrawn new guidelines for testing male service members aged 30 and above for testosterone deficiency. These guidelines, issued by the Department, are being revised, with the final clinical guidance expected soon. The Defense Department remains committed to addressing hormone deficiencies, promoting service members' long-term health, and ensuring peak operational performance.
The interim guidance on testosterone deficiency screenings for active duty and reserve personnel remains in effect. The final clinical guidance will be released shortly.
The guidelines, released by the Defense Health Agency, called for screenings and blood tests for active-duty troops and reservists aged 30 and over. Service members diagnosed with hypogonadism, or low testosterone, would receive follow-up screenings and treatment, including testosterone replacement therapy, if necessary. Defense Secretary emphasized that this initiative is about restoring and optimizing natural capabilities, protecting longevity, and ensuring biological readiness for military service.
Written by urgent.news from CBS News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
